NEW YORK (Reuters) - A federal judge on Thursday scheduled a trial for June 2017 in the U.S. government's securities fraud case against former pharmaceutical executive Martin Shkreli, who became a lightning rod last year for outrage over soaring prescription drug prices.
Read more
No comments:
Post a Comment